FMR1 Carriers Report Executive Function Changes Prior to Fragile X-Associated Tremor/Ataxia Syndrome: A Longitudinal Study

Mov Disord. 2024 Mar;39(3):519-525. doi: 10.1002/mds.29695. Epub 2023 Dec 20.

Abstract

Background: Men with fragile X-associated tremor/ataxia syndrome (FXTAS) often develop executive dysfunction, characterized by disinhibition, frontal dyscontrol of movement, and working memory and attention changes. Although cross-sectional studies have suggested that earlier executive function changes may precede FXTAS, the lack of longitudinal studies has made it difficult to address this hypothesis.

Objective: To determine whether executive function deterioration experienced by premutation carriers (PC) in daily life precedes and predicts FXTAS.

Methods: This study included 66 FMR1 PC ranging from 40 to 78 years (mean, 59.5) and 31 well-matched healthy controls (HC) ages 40 to 75 (mean, 57.7) at baseline. Eighty-four participants returned for 2 to 5 follow up visits over a duration of 1 to 9 years (mean, 4.6); 28 of the PC developed FXTAS. The Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) was completed by participants and their spouses/partners at each visit.

Results: Longitudinal mixed model regression analyses showed a greater decline with age in PC compared to HC on the Metacognition Index (MI; self-initiation, working memory, organization, task monitoring). Conversion to FXTAS was associated with worsening MI and Behavioral Regulation Index (BRI; inhibition, flexibility, emotion modulation). For spouse/partner report, FXTAS conversion was associated with worsening MI. Finally, increased self-report executive function problems at baseline significantly predicted later development of FXTAS.

Conclusions: Executive function changes experienced by male PC represent a prodrome of the later movement disorder. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Keywords: CGG‐repeat; FMR1 gene; attention; executive dysfunction; fragile X; fragile x‐associated tremor/ataxia syndrome; inhibitory control; neurodegeneration; trinucleotide repeat; working memory.

MeSH terms

  • Adult
  • Ataxia
  • Cross-Sectional Studies
  • Executive Function / physiology
  • Fragile X Mental Retardation Protein / genetics
  • Fragile X Syndrome* / complications
  • Fragile X Syndrome* / genetics
  • Humans
  • Longitudinal Studies
  • Male
  • Movement Disorders* / complications
  • Tremor

Substances

  • Fragile X Mental Retardation Protein
  • FMR1 protein, human

Supplementary concepts

  • Fragile X Tremor Ataxia Syndrome